Skip to main content
Equibles

Robertson Stephens Wealth Management, LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1767307 San Francisco, CA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$43,817
+$3,443 QoQ
Shares Held
15,649
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 62 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Robertson Stephens Wealth Management, LLC holds $4,144,185 across 13 Biotechnology names. ANIX ranks #10 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 14,682 $1,028,180
2 ALNY
Alnylam Pharmaceuticals, Inc.
 2,782 $837,465
3 INCY
Incyte Corp
 6,672 $756,337
4 CTMX
CytomX Therapeutics, Inc.
 96,000 $360,000
5 CUE
Cue Biopharma, Inc.
 11,133 $351,357
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 420 $208,626
7 RLMD
Relmada Therapeutics, Inc.
 25,000 $173,000
8 ACHV
Achieve Life Sciences, Inc.
 25,000 $163,250

All Filings in ANIX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,817 15,649
2026-03-31 $40,374 15,649
2025-12-31 $48,824 15,649
2025-09-30 $51,641 15,649
2025-06-30 $51,641 15,649
2025-03-31 $44,756 15,649
2024-12-31 $36,305 15,649
2024-09-30 $49,294 15,649
2024-06-30 $56,684 25,649